Press Releases :: XORTX Therapeutics Inc. (XRTX)

Apr 20, 2022 7:00am EDT

XORTX Receives Small and Medium Enterprise Status for the European Union

Apr 12, 2022 7:00am EDT

XORTX Receives No Objection Letter from Health Canada

Apr 07, 2022 7:00am EDT

XORTX Announces Grant of US Patent

Mar 31, 2022 7:00am EDT

XORTX Files IND with US FDA

Mar 23, 2022 7:00am EDT

XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection

Mar 14, 2022 7:00am EDT

XORTX Therapeutics Announces Submission of Clinical Trial Application to Conduct Bridging Pharmacokinetics Study

Jan 31, 2022 7:00am EST

XORTX Provides Corporate Update

Jan 20, 2022 7:00am EST

XORTX Announces Appointment of Chief Technology Officer

Jan 10, 2022 7:00am EST

XORTX to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference

Dec 21, 2021 6:00pm EST

XORTX Reports Annual & Special Meeting Results

rss_feed News RSS